Henry Orozco-Contreras

Henry Orozco-Contreras

Auto-generated profile, based on publicly available information

Henry Orozco-Contreras

Fischell Department of Bioengineering University of Maryland College Park Maryland USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2026 in Acta Biomaterialia
Verified
Journal Article
Open access
ASAmal Shabazz
Amal Shabazz
JFJulia Fitlin
Julia Fitlin
HOHenry Orozco-Contreras
Henry Orozco-Contreras
SGShengbo Guo
Shengbo Guo
LZLijie Grace Zhang
Lijie Grace Zhang
JFJohn P. Fisher
John P. Fisher
The repair of soft tissue defects remains a leading clinical challenge for patients with active lifestyles, unintentional falls and injuries, cancer, and age-related diseases. Tissue engineering and 3D printing have been developed over the last decades as strategies to create personalized tissue mimics by precisely depositing biomaterials and cells to fabricate static constructs. However, long-term clinical solutions call for increasing the complexity of engineered models to incorporate bioactive processes that mimic the dynamic nature of human tissues. 4D printing has therefore become a growing strategy for building soft tissue constructs that exert function with time. The critical challenge lies in balancing biologically relevant tissue-specific function with programmable material capabilities in response to environmental stimuli. This review highlights the technological advancements that have improved progress in soft tissue engineering to build complex skin, cardiovascular, nerve, skeletal muscle, and connective tissue constructs. We first discuss mechanisms for 4D material actuation through external stimuli, which, when combined with advanced additive manufacturing tools, can assemble and program responsive tissue mimics. We next address progress in engineering functional soft tissues, which are characterized by tissue type, and discuss their limitations. Finally, the challenges associated with the fabrication of next generation 4D printed soft tissues are defined, and emerging frontiers are highlighted. STATEMENT OF SIGNIFICANCE: Soft tissue regeneration remains a clinical reconstructive challenge due to the hierarchical nature and intricate mechanics of native tissue. While 3D printing is an effective strategy for short-term healing outcomes, most tissues in the human body rely on dynamic properties to support normal physiological function. 4D printing strategies offer improvements in complexity to embed tissue-specific function into bioprinted constructs. Many existing reviews thoroughly cover 4D printing technologies and stimuli; however, their applications in soft tissue engineering toward prototyping functional tissue mimics remain underexplored. This review explores programmable stimuli for 4D printed soft tissues, advancements and limitations in function classified by soft tissue type, and insights and strategies for future challenges to work toward 4D printed functional, engineered soft tissues.

4 October 2026 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Open access
PDF file
ASAmal Shabazz
Amal Shabazz
JFJulia Fitlin
Julia Fitlin
HOHenry Orozco‐Contreras
Henry Orozco‐Contreras
CNCassandra Nti
Cassandra Nti
WHWilliam Pieper Holeman
William Pieper Holeman
JFJohn P. Fisher
John P. Fisher
The rapid growth of additive manufacturing technologies continues to drive the commercial development of standardized materials to streamline the process. Despite the growing range of available materials, few still achieve a balance between flexibility and biocompatibility. Here, we evaluated the cytotoxicity of Formlabs Biomed Elastic 50A, Biomed Flexible 80A, and Biomed Durable resin using normal human dermal fibroblasts and human mesenchymal stromal cells. The sol fraction of the crosslinked and uncrosslinked materials was measured to determine the amount of leachable components in the polymer network. Following ISO 10993‐5 guidelines, cytotoxicity was evaluated through direct, indirect, or extract testing for 24 h. All three materials did not elicit a cytotoxic response when assessed through fluorescence imaging and LDH assay. In each test, cells showed similar viability as cells cultured with a known noncytotoxic control, polycaprolactone, and showed significantly higher viability compared to a cytotoxic control, a polyurethane film containing 0.1% zinc diethyldithiocarbamate (ZDEC). Post‐processing parameters were shown to minimize the effects of cytotoxicity when post‐treated with an isopropyl alcohol wash, UV post‐curing, or ethanol sterilization. Overall, the Formlabs Biomed Elastic 50A, Biomed Flexible 80A, and Biomed Durable resins were shown to exhibit minimal cytotoxicity after printing and post‐processing. Further, the presented findings can be adapted to standardize in vitro testing of a wide range of commercial photocurable resins for tissue‐interfacing parts.